Laddar...
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
The development of new lymphatic vessels occurs in many cancerous and inflammatory diseases through the binding of VEGF-C to its receptors, VEGFR-2 and VEGFR-3. The regulation of VEGFR-2/VEGFR-3 heterodimerisation and its downstream signaling in lymphatic endothelial cells (LECs) remain poorly under...
Sparad:
| I publikationen: | Nat Commun |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6281649/ https://ncbi.nlm.nih.gov/pubmed/30518756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-07514-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|